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1.0 Abstract 
 Current methods to treat orthopedic disorders cannot satisfy the growing demand for 
organ transplants. The main method of providing transplantable organs is organ donation. 
However, the number of available organs pales in comparison to this demand. Regenerative 
medicine could provide an endless supply of organs for transplant by growing them in a 
laboratory. Decellularized Aptenia cordifolia leaf grafts showed promise as scaffolds for 
regenerative tissues. A previous study showed xylem growth between the lamina of grafted 
leaves that can be used as a biperfusable plant-based scaffold. However, those grafted leaf 
scaffolds did not perfuse throughout the entire graft’s vasculature. The development of a fully 
perfusable grafted leaf scaffold is necessary to promote nutrient, gas, and waste exchange to the 
attached regenerative tissue. This study tested the use of mini magnets to promote the adhesion 
of grafted leaves during the graft incubation process. The efficiency of magnet use was 
determined by measuring the perfusion flow rate of red dye through the graft and qualitatively 
observing its area of perfusion. Grafts were also evaluated using histology by observing the 
difference in xylem production ± the use of magnets. This study suggested that there is no 
significant difference between ± magnet use in increasing the graft’s uniformity of perfusion. 
Magnet use, however, slightly increased the graft perfusion flow rate. More research is needed to 
support or reject this conclusion. In addition, this study adapted other graft production methods 
to increase decellularization efficiency. 
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3.0 Introduction 
3.1 Tissue and Organ Demand 
 Orthopedic disorders prevail despite recent scientific developments in regenerative 
medicine (Cengiz et al. 2018). Orthopedic disorders are impairments to the musculoskeletal 
system and include trauma, injury, tumors, infections, and diseases to the musculoskeletal 
system. One limitation to treating these disorders are the lack of tissue and organ donors. As of 
April 2020, over 112,000 patients needed an organ transplant despite the United States providing 
145 million registered donors. Many registered donors cannot provide enough organs because 
direct transplantation relies on matching the donor’s body size, blood type, tissue type, and 
delivery distance to a patient (Health Resources and Services Administration 2019). Therefore, 
these requirements significantly limit donor to patient matches. There are fewer available organs 
and tissues for transplantation than provided through donor transplants alone. 
Regenerative medicine provides additional tissues and organs by using donated or 
recreated laboratory tissue in a process known as regenerative tissue engineering. When 
transplanted, regenerative tissues encourage the body’s original tissue to grow and replace 
damaged or missing tissue in the body (Living Beyond Breast Cancer 2020). If they are not 
transplanted from a donor, they may be grown in a laboratory on scaffolds such as the 
extracellular matrices of decellularized tissue or organs. Decellularization is the process of 
thermally or osmotically shocking, mechanically disrupting, or chemically stripping cells so that 
only the extracellular matrix (ECM) remains. The ECM is the surrounding structural material, 
specialized proteins, and proteoglycans that encompass animal tissue. The ECM allows cells to 
interact to determine their cellular function, homeostasis, development, and repair. So, 
decellularization allows the ECM to provide these functions to seeded cells for growth and 
possible differentiation of regenerated tissues (Xing 2014). Once grown, these regenerative 
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tissues mimic the organic architecture of the surgical locations to return physiological function 
(Damodaran et al. 2018). Therefore, regenerative tissue engineering provides an alternative to 
whole organ donation by growing tissue that improves, maintains, or restores tissue physiology 
(O’Brien 2011). 
3.2 Current Production of Regenerative Tissues 
 Today, researchers engineer numerous types of regenerative tissues and their 
manufacturing processes which come from either natural or synthetic sources. Examples of 
various types of regenerative tissues, their biodegradability, possibility of inflammation, and 
biocompatibility are found in Table 1: 
Table 1: Example of Natural and Synthetic Scaffolds (Moroni et al. 2008) 
Biomaterial Biodegradability Inflammation Biocompatibility 
PLA* 5 mos-5 yrs Local Metabolic pathway 
degradation, enzymatic 
hydrolysis 
PEOT/PBT* 1 mos-5 yrs None to mild 
foreign body 
reaction 
Hydrolysis 
POEs* 1 wk-6 mos Minimal Metabolic pathway 
degradation 
PPF-DA* 6 mos-3+ yrs Minimal Hydrolysis 
Collagen † Crosslinks to stable form 
in about 1 d 
Minimal, none to 
mild cytotoxicity 
Does not degrade 
Alginate † 1 d-3 mos None, none to 
mild body 
reaction 
Does not degrade 
Chitosan † 3 d-6 mos None, none to 
mild body 
reaction 
Hydrolysis 
Hyaluronate † A few hrs- 1 mos None, none to 
mild body 
reaction 
Hydrolysis 
* Synthetic Scaffold, † Natural Scaffold 
Table 1 reveals the wide but limited uses of natural and synthetic scaffolds. For example, 
when combined with glycosaminoglycans, type I and II collagen have been widely used as very 
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porous scaffolds for tissue repair but may cause mild cytotoxicity in the body. PPF-DA is an 
example of a synthetic scaffold that can mold to its environment and provide moldable structure 
for cells to grow on. However, it may produce remnant acrylics thereby causing a minimal toxic 
reaction in a patient. 
These scaffold materials can be used to construct a limited variety of organs for 
transplantation. Table 2 reveals which organs a scaffold made of each biomaterial can 
successfully produce: 
Table 2: Scaffold Materials Tissue Engineering Potential (Moroni et al. 2008) 
Biomaterial Skin Cartilage Bone Ligaments Tendons Vessels Nerves Liver Pancreas 
Alginate† X X X   X X X  
Chitosan† X X X   X X X X 
Collagen† X X X X X X X   
PLA* X X X X X X X X  
Hyaluronate† X X X X   X X  
PEOT/PBT* X X X       
POEs*   X       
PPF-DA*   X   X    
* Synthetic Scaffold, † Natural Scaffold 
For example, PLA is a synthetic material that can produce up to eight different types of 
tissue engineered organs while POEs is limited to one material. However, it is equally important 
to consider the scaffold limitations provided in Table 1. This is because while POEs is limited to 
engineer bone, it has a significantly faster biodegradation rate than PLA which may shorten the 
duration of inflammation if it occurs. For this reason, regenerative tissue products and scaffolds 
require specific criteria to successfully interact with the patient after transplantation as described 
in sections 3.2.1 through 3.2.2. Then, types of regenerative tissue will be further considered in 
section 3.2.3. 
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3.2.1 Regenerative Tissue Criteria 
 Biocompatibility 
Regenerative tissue must be biocompatible with the patient’s body. So, the tissue product 
must not provoke an immune reaction after transplantation to prevent product rejection and 
subsequent harm to the patient. If a scaffold is used, the tissue must also be biocompatible to the 
scaffold. Meaning, it must attach, grow, and proliferate with no harm caused to the tissue product 
or scaffold. 
Low Production Cost and Adequate Availability 
A regenerative tissue product must be cost effective and readily available to patients. 
Cost effectiveness would provide these products an advantage in the market. Greater availability 
would provide more tissue to more patients (Hunsberger et al. 2015). 
3.2.2 Scaffold Criteria 
 Some tissues use artificial or natural scaffolds as surfaces to grow regenerative tissue. 
Used scaffolds must have the following criteria: 
Biodegradability 
A scaffold must be biodegradable because it usually does not aid in wound healing as a 
permanent implant. Its degradation must allow the tissue and body cells to replace the scaffold’s 
extracellular matrix with body cells. Therefore, the scaffold provides an architectural basis for 
body cells to replace and restore physiological function. This degradation must be non-toxic. It is 
optional whether the scaffold material is designed to safely leave the body (O’Brien 2011). 
Diffusible or Perfusable Architecture 
The scaffold must have a diffusible or perfusable architecture to promote the distribution 
of nutrients and waste products across the growing tissue. Synthetic scaffolds must be engineered 
to contain either pores for diffusion or for a proper vascular system for perfusion of nutrients, 
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gases, and waste. This vascular system consists of two important features: vasculature and 
microvasculature. Vasculature refers to tissue vessels greater than 10 µm in diameter that 
circulate fluids while microvasculature refers to similar vessels, but with a diameter of less than 
10 µm (Jain et al. 2005). They must have either adequately sized pores or a complete vascular 
system to allow new cells to travel around and bind to the inside of the scaffold while also 
forming a definitive scaffold surface (O’Brien 2011). Exposing regenerative tissue to a 
perfusable vascular system may stimulate growth and produce a thicker tissue layer or a full 
organ (Wang et al. 2020). Natural scaffolds already have a vasculature and microvasculature, 
which can be used as this perfusable architecture. 
3.2.3 Tissue Types 
Depending on the tissue source and product destination, regenerative tissues can either be 
allogeneic, autologous, or xenogeneic. Sections 3.2.3.1 through 3.2.3.2 describe these types of 
tissues with greater detail, including descriptions of pro et contra. 
3.2.3.1 Allogeneic Tissue 
Allogeneic tissue therapies use tissue products from donors that doctors modify and 
transplant into genetically different recipients of the same species. Any human recipient may use 
these products regardless of his or her genetic disposition (Hunsberger et al. 2015), but the 
patient may require immunosuppression drugs to prevent the body from targeting the tissue in an 
immune reaction (Siemionow et al. 2015). Allogeneic tissues may contain donor-specific 
antibodies and DNA that cause the patient’s body to recognize the tissue as foreign and cause an 
immune reaction (Damodaran et al. 2018). Therefore, chronic immunotherapy may require 
indefinite suppression of this immune reaction against this tissue. This use of chronic 
immunotherapy is an inconvenience in a patient’s day-to-day life. However, not all immune 
systems reject foreign tissue: some patients’ immune systems may be hyporesponsive to donor 
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specific tissue by not recognizing the tissue as foreign and therefore accept the tissue 
(Siemionow et al. 2015).  
Allogeneic tissues can be mass produced in a “scaled up” production line and stored until 
needed because of their ability to be universally donated. However, mass producing them 
requires real-time monitoring and maintenance to promote product viability (Hunsberger et al. 
2015). 
3.2.3.2 Autologous Tissue 
Autologous tissues are patient cells modified into a regenerative tissue product for same 
patient use (Hunsberger et al. 2015). Since these products come from the original donor, the 
immune system recognizes these regenerative tissues are composed of native cells and does not 
reject them (Goyer et al. 2019). Unfortunately, it is not possible to “scale up” allogeneic tissue 
production because the tissue’s genetic disposition must match the patient’s (Hunsberger et al. 
2015). 
3.2.4 Regenerative Tissue Engineering Methods 
  Regenerative tissues can be manufactured through various methods including 
xenotransplantation, self-assembly, bioprinting, and with decellularized scaffolds. Sections 
3.2.4.1 through 3.2.4.3 describe these tissue assembly methods in detail with pro et contra. 
3.2.4.1 Xenotransplantation 
 Xenotransplantation consists of transplanting tissues or organs across different species; 
the donor is from a different species than the recipient. Pigs are commonly used for xenogeneic 
tissue because they share a physiology similar to humans in their immunology, anatomy, and 
physiology. They have similarly sized organs to humans when grown to a certain size, are easy 
to breed and handle, and pigs quickly reproduce (Hammer 2003). Xenotransplantation has a 
broad variety of animals to use for regenerative tissue development, so the method is not limited 
to pigs. (Hickey et al. 2018).  
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Moreover, there are several drawbacks to using xenotransplantation. The use of any 
animal for xenotransplantation poses the risk of transmitting zoonoses, or diseases transferred 
from animals to humans (Hammer 2003). Examples of zoonotic diseases range from viral, 
bacterial, or fungal infections which have varying severities in humans such as SARS, influenza 
H5N1, scrub typhus, Brucella, Clostridium difficile (Makenzie and Jeggo 2019). 
Xenotransplantation also has a high immunological rejection rate for the same reason allogeneic 
tissue is commonly rejected; foreign antigens are present on the transplanted tissue’s cells. The 
most common foreign antigen is galactose-α [1,3]-galactose (commonly known as 𝛼𝛼-Gal 
epitope) found on many non-human cell surfaces, but rarely present on human cells. Researchers 
have genetically modified pigs to not have the 𝛼𝛼-Gal epitope displayed on their cell surfaces to 
prevent an immune response. However, non-Gal antibodies will still attach to the xenograft to 
signal for an immune response a few weeks after transplantation (Damodaran et al. 2018). 
Xenotransplantation is also controversial from an ethical perspective. For example, religious 
patients who are Muslim or Jewish may not want a xenotransplant derived from a pig scaffold 
because pigs are forbidden to consume. Similarly, vegans or vegetarians may not want to exploit 
animals for the production of these tissues (Hammer 2003). 
3.2.4.2 Three-Dimensional Bioprinting 
Additive manufacturing, further known as three-dimensional (3D) bioprinting, uses a 3D 
printer to form tissues and organs specific to a computer design model. Bioprinting involves 
imaging a patient’s damaged tissue and transplantation site, designing a tissue model in a 3D 
printing program, and printing the tissue using materials and cells specific to the transplantation 
site’s anatomy and physiology. These printers popularly use materials like decellularized ECMs 
and natural polymers. A polymer is a chemical compound made of a string of repeating 
monomer units. This printed tissue could be matured in a bioreactor prior to transplantation. For 
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example, researchers have 3D printed “organs-on-a-chip”, which are used to detect the presence 
of vaccines and drugs. However, some printed monomers or oligomers cause cellular 
inflammation and their use must be avoided during the scaffold production process. Regardless, 
researchers are determined to 3D print life size tissues and organs to be safely transplanted into a 
patient. (Murphy and Atala 2014) 
An example of pioneer work for producing 3D printing organs is Grigoryan et al. 
(2019)’s study. Grigoryan printed the photosensitive monomer tartrazine, which forms a polymer 
after activation with ultraviolet light and other aggregates to form 3D hydrogels. The researchers 
3D printed a lung vascular network using this polymer that could functionally transport human 
red blood cells and oxygen to the growing regenerative tissue. In addition, this hydrogel may be 
formed in whatever shape and vasculature desired and may serve as a scaffold for regenerative 
tissue growth. They seeded rat liver cells into this hydrogel and transplanted it into rats with 
chronic liver injury to determine if this hydrogel successfully restored rat liver function. After 14 
days from transplantation, the liver cells survived with hepatocytes adhering to the hydrogel and 
host blood inside the structure. This news reflects the successful progress in 3D printing 
transplantable organs to restore physiological function (Grigoryan at el. 2019). 
3.2.4.3 Decellularized Scaffolds 
Decellularized scaffolds consist of a sampled tissue containing an ECM that provides a 
scaffold surface for cells to adhere, grow, disperse, and proliferate into a regenerative tissue 
(Tapias and Ott 2014). These scaffolds are fabricated by removing cells surrounding the ECM 
through decellularization (Hickey et al. 2018). A sampled tissue may or may not have a 
diffusible membrane or natural vascular system to disperse important molecules across the 
scaffold to feed adhering cells. The presence of this structure depends on the scaffold’s source. 
Decellularized scaffolds vary in source kingdoms and in their ability to disperse important 
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molecules. Examples of decellularized scaffolds are described in more detail in sections 3.2.5.1 
through 3.2.5.2.2. 
3.2.5 Caveats in Regenerative Tissue Engineering in Relation to Their Vascular Systems 
Methods to develop lab-based regenerative tissue come with caveats that limit their 
functions. Specifically, each method limits the production of a proper vascular system to 
promote regenerative tissue growth. The efficacy of these methods stems from the regenerative 
tissue’s source. 3D bioprinting does not provide a preexisting vascular system but instead 
requires the production of an artificial one. In contrast, xenotransplantation and decellularized 
scaffolds have natural vascular systems. 
There are challenges in culturing complex tissues and organs using 3D cellular printing 
without a preexisting vascular system. Tissues and organs require the ability to exchange 
nutrients, gases, and wastes necessary for maintaining cellular metabolic function and growth. 
Current 3D cellular printing cannot easily replicate this ability in natural tissue because to date 
the printers cannot recreate a small enough vascular system to disperse nutrients (Jain et al. 
2005). 3D printed capillaries are limited to 50-110 µm in diameter but (Grigoryan et al. 2019 and 
Lee et al. 2019) but the human microvasculature is about 5-10 µm in diameter (Wiedeman, 
1963). To print an adequate microvasculature, researchers must develop a 3D printer that can 
print a tenth of the diameter of the vasculature to produce that of the capillary system which is 
not currently available. 
Allogeneic tissues, autologous tissues, and decellularized scaffolds, however, all provide 
a natural vascular system because they are derived from living sources (Crapo et al. 2011). 
Therefore, researchers have focused on using these tissue sources for regenerative tissue 
production. 
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3.2.5.1 Animal Scaffolds 
 Researchers have successfully decellularized a variety of organs such as heart, liver, skin, 
muscle, sis mucosa, kidney, nerve, tendon, blood vessel, and ligament from different animal 
models including pigs and dogs to demonstrate their ability to function as decellularized 
scaffolds (Ventura et al. 2019). For example, Park and Woo (2012) decellularized most major 
solid organs such as the heart, kidney, liver, stomach, spleen, and intestines within an 
anesthetized rat by perfusing decellularizing liquid mainly through the carotid artery. The organs 
were harvested from the rat after decellularization and tested for their vascular structure and 
histology. Thus, Park and Woo (2012) demonstrated that multiple decellularized animal 
scaffolds with complex vascular structures can originate from a single donor (Park and Woo 
2012). 
Ott et al. (2008) extended this animal-based scaffold research by recellularizing these 
animal scaffolds to restore organ physiology. Recellularization is the process of uniformly 
repopulating organ or tissue specific cells within a scaffold’s decellularized ECM (Tosun and 
McFetridge 2013). Ott et al. (2008) recellularized a previously decellularized rat heart with rat 
endothelial or cardiac cells. They then placed the recellularized organ in a bioreactor that 
mimicked cardiac physiology by perfusing an oxygenated culture medium to the heart cells and 
provided electrical stimulation. This recellularization process restored the organ’s cells and 
heartbeat contractions after about eight days in the bioreactor. Therefore, Ott el al. (2008), 
provided a protocol for recellularizing previously decellularized organs to restore organ 
physiology. 
Uygun et al. (2010) further extended animal scaffold research by demonstrating a 
functional protocol for decellularizing and recellularizing a rat liver graft that can be transplanted 
into rats with restored physiology. That study decellularized a rat liver graft and recellularized it 
16 
 
via the primary portal vein with primary rat hepatocytes. The study histologically studied the rat 
liver graft over 5 days to visualize any changes in cellular positions within the ECM. They found 
that the recellularized cells remained intact and organized in and around the vessels as well as the 
extracellular matrix after recellularization. These cells remained viable and restored liver 
function after transplantation into a live rat (Uygun et al. 2010). Taken together these three 
studies showed animal scaffolds have potential to be decellularized, recellularized, and 
successfully transplanted into living organisms resulting in functionality. 
Despite the potential use in regenerative medicine, animal scaffolds require an animal 
source which inherently costs more due to animal production than other scaffold sources such as 
plants. There is also the risk of zoonotic disease transmission between the animal scaffold source 
and humans. 
3.2.5.2 Plant Scaffolds 
 To remove the possibility of zoonotic transmission, researchers have patented different 
methods for creating decellularized scaffolds sourced from different types of plant tissues. The 
rationale behind developing these tissues can be found in section 3.2.5.3 Recently, several teams 
have made decellularized scaffolds out of plant materials including spinach, parsley, Artemisia 
annua, and peanut hairy roots (Gershlak et. al 2017), apple hypanthium (Modulevsky et al. 
2014), and Aptenia cordifolia (ice plant) leaves (Wang et al. 2020). Plant materials using pre-
vascularized plant tissues (leaves, stems, and roots) provided a unique scaffold compared to non-
vascularized tissue like apple hypanthium. Pre-vascularized leaves provided a natural vasculature 
and microvasculature, thereby eliminating the need to recreate such vasculature as required 3D 
printing processes (Gershlak et al. 2017, Modulevsky et al. 2014, Wang et al. 2020). In addition 
to the removal of zoonotic diseases, plant scaffolds cost less than animal and human derived 
tissues (Hickey et al. 2018). Therefore, plant scaffolds can be mass produced at a lower cost. 
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Some plant scaffolds are easily molded (Hickey et al. 2018) like apple hypanthium, which can be 
cut into desired shapes to fit a patient’s transplantation site (Modulevsky et al. 2014).  
3.2.5.3 Plant Scaffold Physiology 
 Tracheophytes, or vascular plants such as trees, flowers, and ferns have 
conducting tissue that transports water and nutrients from sources such, as roots, to sinks, such as 
leaves. A tracheophyte’s vascular tissue is specialized to transport water through the xylem and 
photosynthetic products through the phloem. More specifically, xylem is a plant’s vascular 
system specially designed to distribute water and ions from the plant’s roots to other areas of the 
plant for photosynthesis and homeostasis. It uses turgor pressure to draw water from the highly 
concentrated areas in the soil to lower concentrated areas inside the plant. This turgor pressure is 
produced when the plant opens its stomata for CO2 sequestration. Opening the stomata releases 
water from the plant into the atmosphere, therefore increasing the negative pressure of 
transpiration and drawing water up the plant (Venturas et al. 2017). 
 The xylem is composed of dead and interconnected cells called tracheary elements that 
transport water and minerals. These tracheary elements are made of various types of non-living 
cells such as tracheids and vessels found in all vascular plants. Through programmed cell death, 
living protoxylem cells develop into non-living tracheary elements when they create secondary 
cell walls with cross-linked cellulose and lignin. Cellulose is a repeating polymer of β-D-glucose 
units that are tightly bonded together to reinforce cellulose fibers into microfibrils. These 
microfibrils are linked together into a microfibril matrix by various polysaccharides known as 
hemicelluloses. Lignin is an important crosslinked polymer that is deposited into this secondary 
cell wall matrix to increase its rigidity. This increased rigidity prevents the xylem from 
collapsing due to the negative pressure produced inside the xylem during water transport. The 
addition of this secondary cell wall elongates and thickens the cell walls, which then undergo 
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programmed cell death to form hardened and interconnected tracheary elements for water 
transport (Taiz et al. 2018). Figure 1 shows sections of xylem from an A. thaliana stem: 
 
Figure 1: Photo A reveals different formations of the xylem’s vascular bundles where the open 
arrow points to primary xylem while the closed arrow points to secondary xylem. Photo B’s 
scale bar is 100 μm long. Photo B zooms in on primary xylem and xylem vessels that are 
indicated with asterisks. Photo B’s scale bar is 10 μm long (Open access: taken from Tixier et al. 
2013). 
It is necessary to grow xylem vessels to connect grafted leaves because the xylem serves 
a as a natural vascular conduit to transport not only water but nutrients to the regenerative tissue. 
It is hypothesized that the more xylem produced to connect both leaves, the greater the perfusion 
that will occur between the two leaves to increase nutrient, gas, and waste exchange. 
3.2.5.2.1 Gershlak et al. (2017) Study 
 Gershlak et al. (2017) demonstrated that various types of vascularized plant scaffolds can 
be decellularized using SDS and Triton X/bleach solution. This study decellularized spinach, 
parsley, annua leaves (SAM cultivar), and peanut hairy roots either via perfusion through a 
cannula or by submersion in the decellularization solutions. The scaffolds transported fluids and 
microparticles through the plants’ vascular systems as demonstrated via the perfusion of Ponceau 
red dye, microspheres, and red blood cells. Gershlak et al. (2017) recellularized the spinach leaf 
scaffolds with human endothelial cells to colonize the inner wall of the plant’s vasculature. Then, 
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human mesenchymal stem cells and human pluripotent stem cell derived cardiomyocytes were 
cultivated on the outer surface of the decellularized spinach leaf scaffolds. The experimental 
procedure is shown in Figure 2: 
 
Figure 2: Gershlak et al. (2017)’s Experimental Procedure. The leaf was decellularized via 
cannulation and perfusion of a Triton X and bleach solution or submerged until the leaf appears 
completely white. The decellularized leaf was then tested for decellularization’s effectiveness, 
the leaf’s vascular integrity, and ability to be recellularized with human cells (Open access: taken 
from Gershlak et al. 2017). 
 
The cardiomyocytes that colonized the leaf surface produced electrical shocks that allowed the 
cells to perform their physiological function to beat creating contractions of the cardiac cells 
across the plant scaffolds (Gershlak et al. 2017). 
Gershlak et al. (2017), thus, provided proof-of-concept that decellularized plant scaffolds 
are a viable method to produce regenerative tissue in lieu of more expensive or less available 
options such as animal scaffolds and human donor transplantation. More research, however, 
must be conducted to determine if the regenerative tissue grown on plant scaffolds can be 
successfully transplanted into humans without noxious consequences. 
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The Gershlak study unfortunately did not produce a plant scaffold that could create a 
flow of nutrients, gas, and waster through the cells to promote cell proliferation. Indeed, while 
there was an input flow via the leaf petiole, liquid entering the leaf had no specific output port; 
solutions leaked out of the distal end of the leaf. To address this shortcoming, the Wang et al. 
(2020) study addressed how to create a biperfusable plant scaffold. 
3.2.5.2.2 Wang et al. (2020) Study 
Wang et al. (2019) grafted Aptentia cordifolia leaves together to connect both leaf 
vascular systems together to create a biperfusable plant scaffold. That study later provided a 
method of culturing human cells on grafted and decellularized A. cordifolia leaf scaffolds to 
provide input and output ports for distributing fluid, e.g. blood, flow. Specifically, Wang et al. 
(2020) grafted two leaves via their lamina and obtained xylem growth between the leaves: grafts 
subsequently supported mammalian cell growth. 
After allowing the leaves to grow together for four weeks, Wang et al. (2020) used 
hexane to remove the waxy outer cuticle of the grafted leaves. The grafts were decellularized 
using sodium dodecyl sulfate (SDS) and a mixture of 0.1% Triton-X with 1% bleach (T/B) so 
only the graft’s ECM remained. (Gershlak et al. 2017). After the decellularization process, Then, 
Wang et al. (2020) tested the graft’s vascular system by separately perfusing Ponceau red dye 
and then red blood cells through both petioles to visually observe the graft’s perfusion pattern. 
The graft perfused through one petiole and out the other petiole to demonstrate that both leaves 
had grown a connecting vascular system, thus producing a “biperfusable” scaffold. Wang et al. 
(2020) further investigated the grafts’ vascular system with histological analysis that showed 
successful xylem connections between the two leaves. Lastly, Wang et al. (2020) cultured 
mammalian breast cancer cells containing a green fluorescent protein (GFP) tag onto these grafts 
to provide visual confirmation that the cells attached to and proliferated on the scaffold surface 
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by observing green fluorescence of the cells via electron microscopy (Wang et al. 2020). Wang 
et al. (2020) thus demonstrated a method for developing a biperfusable plant scaffold that also 
supported mammalian cell growth and proliferation on its surface. 
3.2.6 Caveats in Plant Scaffold Studies 
3.2.6.1 Caveats in Gershlak et al. (2017) Study 
 Gershlak et al. (2017) remarked that their study used highly concentrated detergents 
during the decellularization process that may be hazardous to humans. If small amounts 
remained within the plant scaffold during the decellularization process, then those toxic 
chemicals could be transplanted into the human body with the regenerative tissue. The Gershlak 
et al. (2017) study attempted to remove any residual detergents via perfusion of deionized water 
but did not confirm whether residual detergents remained within this scaffold. 
 Gershlak et al. (2017) also stated that, to their knowledge, no one had yet determined 
whether their scaffold is non-toxic or if it could elicit an immune response. They reported that 
decellularized cellulose is both biodegradable and biocompatible, which would prevent an 
immune response and would degrade inside the body over time. The same team successfully 
transplanted these scaffolds into rats with a minimum immune reaction in a study to be published 
in the future (Gaudette 2020, unpublished results). This study reveals how the human body could 
accept the transplantation of whole decellularized plant tissue. 
3.2.6.2 Caveats in Wang (2019) Study 
Wang et al. (2020) reported that the A. cordifolia scaffold produced a non-uniform 
perfusion across the scaffold area when compared to previous experiments using other plant 
species. “Uniform” refers to the solution perfusing throughout the entirety of the grafted leaf 
scaffolds. Gershlak et al. (2017) recorded red dye perfusing first through the large central vein, 
then through the branching minor veins. However, Wang et al. (2020) reported that the A. 
cordifolia scaffolds perfused first through the leaf marginal veins and then through the large 
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central vein. Wang et al. (2020) remarked that this difference may be due to gap formation 
between the leaves during the grafting process. This difference could be due to the production of 
non-uniform vasculature formation after grafting, the presence of trapped air bubbles, or the 
breakdown of the grafted leaf during specimen processing or staining. Wang et al. (2020) 
addressed the possibility of a gap formation by using magnets to hold the leaves more closely 
during grafting (Wang 2020). However, Wang (2019) did not validate that the use of magnets 
during the grafting process improved graft perfusion. 
3.2.7 Addressing Regenerative Tissue Caveats 
This study aims to advance the growth of regenerative tissue on decellularized plant 
scaffolds for use in regenerative therapies, specifically by improving the grafts as described by 
Wang et al. (2020). Furthermore, this study will focus on improving the connection of grafted 
leaves to promote uniform fluid flow across the graft’s connected vasculature system. A uniform 
fluid flow would enhance the feeding of nutrients, gases and waste removal for mammalian cells 
growing on the grafted leaf scaffold. 
To improve the microvasculature perfusion pattern in grafted leaves, this study will 
explore the effect of graft incubation time on perfusion uniformity. Wang et al. (2020) allowed 
the leaves to grow for at least four weeks before using them in the experiments. Connections 
were determined by histochemically staining xylem to visualize vascular connections between 
both grafted leaves. By using an Haematoxylin and Eosin (H&E) stain on the grafts, Wang et al. 
(2020) determined whether the leaf cells had cell-to-cell contact and cell communication 
between the two scions and leaves.  
Although magnets were used, Wang et al. (2020) did not validate whether or not magnets 
placed at the center of the grafts increased the graft vascular connections that would enhance 
perfusion. Wang (2019) used magnets to presumably reduce the gap formation between the 
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leaves and to increase leaf-to-leaf contact area. Therefore, Wang et al. (2020) reasoned that the 
leaves would regenerate a stronger connecting vasculature system than without the use of 
magnets. It remains unknown how magnets affect the graft’s developing microvasculature 
because Wang et al. (2020) did not compare the perfusion patterns of grafts ± magnets. 
Therefore, this study will determine how magnets affect the graft’s microvasculature growth.  
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4.0 Hypotheses and Objectives 
 This study sought to improve the uniformity of vascular perfusion of through the vascular 
system of A. cordifolia grafts. This study determined whether the presence of magnets affected 
the growth of microvasculature between grafted leaves in relation to the graft’s developed 
perfusion pattern. Graft histology was used to show whether there was an increase in xylem 
proliferation with the use of magnets during the grafting process. 
4.1 Hypotheses 
Hypothesis 1: Magnets will result in better leaf adherence along the midrib of the leaves during 
the grafting process. It was anticipated that this will result in the graft perfusing more uniformly 
and at a faster rate than grafts without magnets. 
Hypothesis 2: Magnets will better adhere leaves along the midrib of the and produce more 
xylem connections between the grafted leaves than without magnets. 
4.2 Objectives 
Objective 1 determined whether the use of magnets successfully produces grafts with 
improved plant vascular connections to provide more uniform perfusion flow patterns and 
potentially a greater rate of flow. The most “successful” grafts were determined by whether they 
perfused flow throughput uniformly across the entire inner leaves. This “uniform” perfusion was 
visually determined with Ponceau red dye perfusion and histological analysis under a bright-field 
microscope. The rate of flow throughput is determined by measuring the volume of flow at 
constant hydrostatic pressure over five minutes. This Objective had two sub experiments: 
1) Establish the impact of magnets on graft perfusion. 
a) Determine the perfusion patterns of grafts ± magnets by red dye perfusion. 
b) Determine the perfusion rate of flow measured in mL/min. 
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Objective 2 queried whether the use of magnets increased the proliferation of xylem between 
grafted leaves. This Objective sought to: 
2) Compare histological analysis results of ± magnet grafts to determine their effect on xylem 
proliferation. 
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5.0 Methodology 
 All grafts were generated and processed using the protocols described in sections 3.1 
through 3.3.1. Some grafts were further processed for Ponceau red dye perfusion using the 
protocol in sections 3.3.2 and 3.4. Other grafts were processed using the protocol found in 3.3.3 
and 3.5. 
5.1 Plant Propagation and Maintenance 
 Aptenia cordifolia (L. f.) schwant plants were grown according to methods described in 
Wang et al. (2020). 
5.2 Graft Generation 
 Aptenia shoots were cut with about one cm of stem still attached to viable leaf. The 
largest viable leaf from each stem cutting was chosen and the cuttings were set aside in pairs 
whose selected leaves match in relative size. One pair of stem cuttings was chosen. One abaxial 
cuticle from one leaf was removed, while one adaxial cuticle from the other leaf we removed. 
These cuticles were removed by carefully cutting small incisions close to the stems using an 
aseptic razor cleaned with 70% ethanol. This incision was cut as shallow as possible and the 
cuticles were peeled off the leaves using aseptic pinchers cleaned with 70% ethanol. Damage to 
the sub-cuticular layers was minimized during the cutting and peeling process. The decuticled 
sides of these leaves were submerged in a plant hormone solution containing 0.1 mg/L 
naphthaleneacetic acid (NAA) (86-87-3, MW:186.21, Sigma) and 1.0 mg/L 6-
benzylaminopurine (BAP) (1214-39-7, MW:225.25, Sigma) hormones for 20 seconds. These 
leaves with both petioles were positioned facing opposite directions and the decuticled sides of 
the leaf facing each other. The two leaves were affixed together so that they touched and pieces 
of plastic mesh (XN3234/5, 0.054” x 0.080” polypropylene, Industrial Netting) were used to 
hold the leaves in place; silicon tubing with side slits sandwiched the plastic mesh on either side 
27 
 
of the leaf graft. If the graft required the use of magnets, magnets (six mm x three mm, 
B07MX57ZGK, Grtard) were added on both sides of the plastic mesh directly in the center of the 
graft site. The graft’s root stems were submerged into water held in glass vials. This grafting 
process was repeated for all samples as demonstrated in Figure 3. All grafted units were placed 
into white trays and shone with continuous warm and cool white artificial lights (F32T8/TL735, 
32 watts, Philips) at a 1:1 ratio onto these graft units at 25℃. If the leaves retained their green 
color and the leaves stuck together after their graft incubation time, those graft units were used in 
the decellularization process. If they did not meet these criteria, then the grafts were discarded. 
 
Figure 3: Example A. cordifolia graft held together by plastic mesh and silicon tubing ± 
magnet held in glass tubes full of tap water. 
 
5.3 Decellularization 
5.3.1 Sutured Graft Preparation 
A27 G needle (305109, Becton Dickinson) was punctured into one of the graft’s stems 
with the needle facing the flow direction toward the graft. The graft’s stem was attached to the 
needle using a surgical suture, tying the suture to grip the needle to the stem as securely as 
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possible without damaging the graft as seen in Figure 4. The sutured grafts were soaked for two 
minutes in 10% Dulbecco’s phosphate-buffered saline (DPBS) (21-030-CVR, Corning) then 
soaked in hexanes (98%, Mixed Isomers, Alfa Aesar, Haverhill, MA) for two minutes. This 
cycle was repeated three times. Then, they were washed for an additional two minutes in DPBS 
for a total of four alternated washings in DPBS and three alternated washings in hexanes. 
 
Figure 4: Examples of sutured A. cordifolia grafts. 
 
5.3.2 Gravity Decellularization 
 After the sutured graft preparation step, the cannula was inserted into one petiole of each 
graft to a gravity decellularization setup as described in Gershlak et al. (2017) and shown in 
Figure 5. The decellularization reservoir was filled with four Liters of 10% SDS solution 
(L3771-1KG, Sigma) and ensured that the SDS only flowed through the needle into the superior 
stem, through the inside vasculature of the graft, and exited from the inferior stem orifice without 
any leakage outside of this system. After all the SDS solution flowed through the grafts, then a 
mixture of 0.5% Triton-X-100 (X100, Sigma) with 1.2% sodium chlorite bleach (Aqua-Tab, 
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Beckart Environmental Kenosha, WI) in deionized water was perfused until the grafts appeared 
translucent and white. This solution was replaced with a minimum of four L of deionized water 
to perfuse through the leaf for at least 24 hrs. Then, the grafts were perfused with Tris buffer 
(T1503, Sigma) at a pH of nine at room temperature for a minimum of 12 hours by placing the 
grafts in this solution in 50 mL conical tubes filled with this solution rotating on the long side of 
the conical tube overnight. this Tris buffer solution was replaced at least twice during this 
process. Then, any remaining Tris buffer was replaced with 50 mL of deionized water and 
rotated for an additional 24 hours within the conical tubes. 
 
Figure 5: Example of an Aptenia graft attached via needle to gravity decellularization setup. 
 
3.3.3 Submersion Decellularization 
 After completing the Sutured Graft Preparation step, the graft was placed into a 50 mL 
conical tube with SDS solution as shown in Figure 6. The conical tube was placed onto a hot dog 
rotator and continuously rotated for 24 hours. Again, the SDS solution was replaced with 1% 
Triton X/1% bleach and place onto the rotator. Then, this solution was replaced every day until 
the grafts were completely bleached white. This solution was replaced with DI H20 for 24 hours. 
Then, this solution was replaced with Tris buffer (T1503, Sigma) at a pH of nine at room 
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temperature for a minimum of 12 hours or overnight. This Tris buffer solution was replaced with 
fresh Tris solution at least twice during this process. After the 12 hour time period,, any 
remaining Tris buffer solution was replaced with 50 mL of deionized water and the conical tube 
rotated for an additional 24 hours. 
 
Figure 6: Example of an Aptenia graft submerged in decellularization solution inside of a 50 mL 
conical tube. 
 
5.4 Red Dye Perfusion 
The perfusion setup was built according to Gershlak et al. (2017). The decellularized 
sample’s 27 G needle was attached to the setup as shown in Figure 7 and perfused 30 mL of 
0.1% (w/v) Ponceau Red (Sigma Aldrich, Saint Louis, MO) solution in 1% (v/v) acetic acid. 
This perfusion was recorded with videos and photos. It was observed whether the dye entered 
through the needle in the superior petiole, perfused across the entire graft, and/or exited through 
the inferior petiole. After perfusion, the graft was submerged in a deionized water bath like the 
one shown in Figure 7 without the stem ends touching the water to observe Ponceau red dye 
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diffuse into the water bath. The ± magnet perfusion patterns were qualitatively compared for 
analysis. 
 
Figure 7: Example of an Aptenia graft attached to the red dye perfusion setup and the 
water bath used for testing graft leakage. 
 
5.5 Histological Analysis 
Histological analysis consisted of observing thin sections of scaffold samples dyed with 
Toluidine blue stain using bright-field microscopy images for differences in xylem generation. 
5.5.1 Histological Slide Preparation 
 The samples were submerged in 4% v/v formaldehyde (3800600, Electron Microscopy 
Sciences) for at least three days. If needed, the samples could have been stored indefinitely in 
70% ethanol after formaldehyde fixation for long term storage. A sponge was placed on the 
bottom of a sample cassette. The decellularized graft was placed into a sample cassette with 
another sponge on top of the sample. The cassette was closed and the sample was placed into a 
tissue processor (ATP1-120, Triangle Biomedical Sciences), processing the cassette with the 
“Short No Fix” program. After the program had finished, the sample was removed from the 
machine and from the cassette. The Paraffin Embedding Station was turned on. The sample was 
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placed into a metal specimen holder and warm paraffin poured on top of the sample, completely 
and evenly covering the sample graft. The metal specimen holder was placed onto the cold bar 
until the paraffin had completely solidified. The paraffin block was removed from the metal 
specimen holder and sliced with two transverse cuts to produce three evenly sized pieces. The 
pieces were placed to stand vertically up onto the metal specimen holder, so the middle edges of 
the graft were exposed on top, as seen in Figure 8. More warm paraffin was poured on top of the 
sample holder, so all of the pieces were conjoined together when dry, also seen in Figure 8. The 
bottom of the cassette was sandwiched onto the wet paraffin, so the cassette stuck to the sample. 
The sample was placed onto the cold bar until the sample was completely frozen. More wet 
paraffin was added to any cracks in between the sample so the pieces were fully conjoined. The 
paraffin block was placed on the cryostat until the paraffin had completely hardened. The 
prepared paraffin block was removed from the metal specimen holder. 
 
Figure 8: Example of dividing the paraffin block sample with two transverse cuts and gluing the 
pieces upright with paraffin in the metal specimen holder. 
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5.5.2 Microscope Slide Staining 
 All of the previously prepared histology microscope slides were placed into a staining 
rack and submerged in xylene for four minutes. The rack was then submerged into a separate 
xylene solution for two minutes. This process was repeated in a second xylene solution. The 
slides were submerged in 100% ethanol for one minute. Then, the slides were submerged into 
95% ethanol for two minutes, and then into 70% ethanol for two minutes. Next, the microscope 
slides were submerged into tap water for two minutes. Using a dropper, a droplet of toluidine 
blue was squeezed onto top of the microscope slide so the stain completely covered the sample. 
The dye sat on top of the sample for one minute. Then, a droplet of mounting media (H157-
475ML, Amresco) was squeezed onto the slide and a cover slip was placed with coverslip glue 
on top of the slide. This slide was set out to dry (WPI Histology Core, 2018). 
5.5.3 Microvasculature Analysis Using Bright-Field Microscopy 
 A stained slide was placed under a bright-field microscope. Photos of the graft were 
taken and all photos were saved to a computer file. Photos were visually compared and noted for 
any differences in graft xylem growth. 
6.0 Anticipated Outcomes  
It was anticipated that using magnets during the grafting process would have improved 
graft perfusion. The magnets presumably pressed the middle of the leaves together to prevent 
gap formation. Therefore, it was thought that this increase in leaf contact area during graft 
growth would have also increased the development of more vascular and microvascular 
connections. 
Therefore, it was hypothesized that four-week-old grafts using magnets during the 
grafting process would have produced the most uniform perfusion across the grafts while the 
experimental control without magnets would have produced the least uniform perfusion. 
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7.0 Results 
7.1 Caveats in Preliminary Study 
In a preliminary study that prepared four decellularized A. cordifolia grafts according to 
the method of Wang et al. (2020), three of the grafts perfused non-uniformly (Figure 9).  
 
Figure 9: Example of the grafted Aptenia leaves showing non uniform dye perfusion. 
 
 
One graft, however, had a more uniform perfusion pattern as shown in Figure 10. This 
successful graft showed that four-week grafts ± magnets seemed to produce a more uniform 
perfusion pattern across the graft’s total area. It was unknown how to reproduce grafts with a 
uniform perfusion. Preliminary studies also encountered some grafts perfusing more uniformly 
than others. Some decellularized grafts did not visually perfuse throughout the entire inner 
surface (therefore, not perfusing “uniformly”). It is important to have uniform perfusion across 
the graft because it provides important nutrients, gases, and waste exchange to regenerative 
tissue grown on a grafted leaf scaffold. 
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Figure 10: Aptenia grafted leaves showing uniform dye perfusion. 
 
 
In other preliminary work, there were problems in producing viable decellularized plant 
scaffolds while using Wang et al.’s methods. First, some leaves separated at the graft site during 
the decellularization process. However, other grafts strongly connected to each other before the 
decellularizing process after their four weeks of growth thereby retaining their connections after 
decellularization. It is possible that some of the unsuccessful grafts may have broken apart due to 
exposure to harsh chemicals to remove the extra plant matter in between the ECM. Alternatively, 
the grafts may have needed a longer grafting exposure time to grow stronger connections 
between the two leaves. 
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7.2 Red Dye Perfusion 
Videos of all red dye perfusion, photos of grafts before and after perfusion, and water 
baths after graft-dipping are found in the following YouTube Video: 
https://youtu.be/5_wX-EEBQlw  
Tables listing the red dye perfusion observations and water bath results are found in Tables 3 and 
4 located in the Appendix. 
These videos and photos reveal that the Ponceau red dye perfused both grafted leaves and 
out the other petiole. However, when both leaf lamina were immersed in water, some grafts 
leaked red dye from the side of the leaves, as seen in video footage and dye leaking into the 
water baths as seen in Figure 11. 
 
Figure 11: (From left to right) Example of a successful graft with no visible leakage, its water 
bath test result, an example of unsuccessful graft with visible leakage, and its water bath test 
result. 
 
The grafts without magnets averaged a perfusion rate of 2.0 mL/minute, while the grafts 
with magnets averaged a perfusion rate slightly faster at 2.2 mL/minute. Unfortunately, due to 
COVID-19 closure, not enough replications were obtained to statistically analyze the data. The 
perfusion pattern data represent only four + magnet grafts and four – magnet grafts. Meanwhile, 
the perfusion rate data represent two + magnet grafts and two – magnet grafts. These 
37 
 
experiments require at least three replications to be analyzed for statistical significance. The raw 
data for these perfusions are found in Table 4 located in the Appendix. 
7.3 Histological Analysis 
Photos of the graft preparation steps and leaf sections were taken and recorded in the 
following YouTube Video: 
https://youtu.be/ozxIKJnmAlQ  
Sections of ungrafted and decellularized Aptenia leaves revealed multiple areas of xylem 
within a leaf, and the vascular tissue was readily observable after decellularizing (Figure 12). 
 
Figure 12: Example xylem found within an Aptenia cordifolia leaf a total magnification 
of 200x. One can see the lignin rings spiraling around the xylem vessel. 
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However, no data from decellularized grafts ± magnet were obtained due to the COVID-
19 shutdown of the laboratory. Therefore, this study could not compare standard leaves versus 
decellularized grafted leaves for analysis of xylem proliferation. For the same reason, this study 
could not compare xylem proliferation between decellularized ± magnet grafts. 
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8.0 Discussion 
Many technologies have been studied for providing transplantable organs to patients 
including production of regenerative tissue (Living Beyond Breast Cancer 2020). Regenerative 
medicine has seen significant progress in recent years yet has several drawbacks and 
requirements to produce viable regenerative tissue. For example, regenerative tissue grown in 
labs must be biocompatible, have a low production cost, and be readily available for 
transplantation when needed (Hunsberger et al. 2015). However, the greatest challenge for 
making these tissues is the lack of or limited use of a vascular system to distribute nutrients, gas, 
and waste exchange or removal. Animal and plant-based scaffolds hold the most potential for 
growing regenerative tissue because they have a natural vascular system for this exchange 
(O’Brien 2011). 
Both animal and plant-based tissue have been shown to have intact vascular systems that 
can be used for cellular nutrient, gas, and waste exchange (Hammer 2003, Gershlak et al. 2017)). 
However, plant-based scaffolds have been more in focus for research because they have a lower 
production cost, minimize cross contamination of diseases (Gershlak et al. 2017), and some plant 
sources like apple hypanthium allow easier scaffold molding (Modulevsky et al. 2014). 
This study advanced the production of a biperfusable plant scaffold for the development 
of regenerative tissue proposed in the Wang et al. (2020) study. This study determined whether 
magnets improved the production of xylem between grafted A. cordifolia leaves. There was no 
noticeable difference in the red dye perfusion pattern between ± magnet grafts. However, since 
there was an inadequate number of replicated experiments to do a statistical analysis of the data, 
this study leaves unanswered the question of magnet utility for improving leaf grafts. Out of four 
graft ± magnets samples each, one – magnet graft and two + magnet grafts had uniform 
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perfusions. As for the water bath tests, all grafts leaked red dye except for a – magnet graft with 
an ununiform perfusion. It also seemed that applying pressure during grafting did not increase 
the graft retention. Nevertheless, this study tested a novel approach to grafting. The Wang et al. 
(2017) study is currently the only recorded method demonstrating the potential of grafting one 
abaxial and one adaxial side of two leaves together. 
In addition, the Wang et al. (2017) study did not measure perfusion flow rate of grated 
leaves. This study suggested, however, that of the few experiments done, grafts with magnets 
perfused red dye at a 10% faster rate than the grafts without magnets by 0.2 mL/min. It is 
recommended that future studies be conducted to validate this conclusion with statistical 
significance. This discovery is important because it reveals how fast nutrients, gas, and waste are 
distributed and removed from the regenerative tissue. Previous studies have not determined the 
perfusion flow rate of plant scaffolds. This perfusion rate can be measured in the future to help 
quantify grafted tissue quality to promote an optimal distribution and removal of nutrients, gas, 
and waste. 
This experiment also studied xylem growth in Aptenia cordifolia leaves. However, no 
images were taken of grafts ± magnet to compare xylem proliferation. Future studies should 
include such images of ± magnet graft sections to compare xylem proliferation between the 
leaves. 
Regardless, this study improved the protocol previously used by Wang 2020 to produce 
the plant leaf scaffolds. It was determined, for example, that larger mesh striations resulted in a 
mesh pattern on the grafts, probably form shading the leaves during incubation; smaller mesh did 
not result in such surface damage. Therefore, thinner mesh striations were used in the grafting 
protocol instead of mesh with thicker striations. The use of rusty magnets also left a rust residue 
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on the graft surfaces after graft incubation. To prevent the transfer of rust onto the graft, new 
non-rusted magnets were used and adapted to the protocol.  
The study also found that using submersion decellularization vs. gravity decellularization 
yielded more robust decellularized grafts, albeit at a slower rate. The gravity decellularization 
step produced grafts that lost their rigid structure over time, sometimes to complete destruction 
of the grafts. The Gaudette lab introduced the use of the submersion decellularization method, 
which maintained better tissue rigidity of the grafts during the decellularization. The submersion 
process required about 7 days to complete instead of the 10 days for the gravity process. The 
same method was used by the Modulevsky et al. (2014) study when decellularizing apple 
hypanthium. The apple hypanthium retained its robust and highly porous structure after 
decellularization (Modulevsky et al. 2014). The submersion decellularization technique appears 
to maintain a better plant extracellular matrix structure when using different plant tissues. To 
keep a greater majority of the grafts intact during the decellularization process, the grafts 
destined for histological analysis used the submersion decellularization method. Therefore, the 
submersion decellularization is the optimal method when decellularizing grafts. 
Lastly, this study discovered that preparing the graft samples using the paraffin processor 
instead of the cryostat produced viable histology sections. It was also determined that Toluidine 
blue successfully stained the xylem for visibility while H&E did not. This was surprising as 
Wang et al. 2020 listed the use of the paraffin processor and the cryostat as viable methods for 
section preparation and Toluidine blue and listed H&E as viable stains. In this study, the paraffin 
processor and toluidine blue were the most effective for preparing samples for histological 
analysis and thus recommended for producing optimal histology sections. 
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9.0 Conclusions and Future Work 
9.1 Conclusions 
 This study attempted to measure the impact of magnets on graft perfusion. Based on the 
information obtained by the red dye perfusion, there was no difference in the perfusion patterns 
of grafts with or without magnets, but more replicates are needed. There was a slight difference 
in the perfusion rate between grafts ± magnets, where the grafts with magnets perfused 0.2 
mL/min faster than the grafts lacking magnets. Unfortunately, no histological data were obtained 
for grated leaves ± magnets. 
This study also adjusted components of Wang 2020’s protocol for preparing 
decellularized grafted A. cordifolia leaf scaffolds. First, large netting and non-rusty magnets 
were used for graft generation. Second, the submersion decellularization method maintained a 
more robust structure of grafts than the gravity decellularization method. The submersion 
method was used for grafts destined for histological analysis. Last, this study determined that 
sections for light microscope viewing were more than adequate using only using the paraffin 
processor prior to staining the grafted sections with Toluidine blue. 
9.2 Future Work 
 Future studies should validate that there is no significant difference in the uniformity of 
perfusion between grafts ± magnets. This study observed the perfusion patterns of four grafts 
each with or without a magnet and provided insight into whether magnets increased uniformity 
of graft perfusion. However, future studies that provide more data points could statistically 
validate this conclusion. Those studies may also validate the discovered perfusion rates. This 
study used five data points in total to determine perfusion rates in grafts made ± magnets. There 
were not enough data points, however, to determine any statistical significance. Future studies 
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may also add perfusion rate data to determine whether grafts with magnets perfused 0.2 mL/min 
faster than grafts without magnets. 
 Lastly, future studies may collect histology data on the grafts ± magnets to determine any 
difference in xylem generation after grafting. Since this study could not collect histological data 
on large number of grafts ± magnets awaiting lost form COVID-19 to analysis, future studies 
may use the histology protocol to determine whether the hypothesis is supported: that the use of 
magnets increases xylem proliferation between grafted Aptenia leaves. It is suggested that future 
studies use the paraffin processor and Toluidine blue staining to complete this histological 
analysis. 
 This study is foundational to strengthening the perfusability of grafted A. cordifolia 
leaves and to promoting a uniform distribution of flow across the entirety of the graft. Future 
studies will determine how to improve these criteria when developing a plant-based scaffold that 
will support regenerative tissue growth and ultimately the production of organs for human 
transplantation. 
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11.0 Appendix 
11.1 Red Dye Perfusion Observation and Rates Raw Data 
 The following Table 3 contains observational notes for each graft perfusion and their 
water bath results: 
Table 3: Graft Red Dye Perfusion Observational Notes and Water Bath Test Results 
 - Magnet + Magnet 
Sample 1 Perfusion through two major 
pathways down leaf, little 
water bath leakage 
Uniform perfusion, lots of 
water bath leakage 
Sample 2 Uniform perfusion, little 
water bath leakage 
Perfusion around leaf edges, 
little water bath leakage 
Sample 3 Perfusion through two major 
pathways down leaf, lots of 
water bath leakage 
Perfusion on one half of graft, 
little water bath leakage 
Sample 4 Perfusion through middle 
only, no water bath leakage 
 
Sample 5  Uniform perfusion, little 
water bath leakage 
 
The following Table 4 displays the amount of red dye perfused within five minutes and 
the calculated red dye perfusion average: 
Table 4: Red Dye Perfusion Rates 
Leaf graft pair - Magnet + Magnet 
Sample 1 3.2 mL/min 2.2 mL/min 
Sample 2 2.2 mL/min 2.2 mL/min 
Sample 3 0.6 mL/min   
Average 2.0 mL/min 2.2 mL/min 
 
